Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient

Clinical Microbiology and Infection

Volumn 16, Issue 10, 2010, Pages 1576-1578

  Chan, P A ^a   Connell, N T ^a   Gabonay, A M ^a   Westley, B ^a   Larkin, J M ^a   LaRosa, S P ^a   Chapin, K ^a,b   Mermel, L ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

H1N1; Immunocompromised; Influenza A; Oseltamivir; Resistance

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; ASPARAGINASE; CEFEPIME; COTRIMOXAZOLE; CYTARABINE; DOXYCYCLINE; METRONIDAZOLE; OSELTAMIVIR; POSACONAZOLE; VANCOMYCIN; ZANAMIVIR;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LUNG INFILTRATE; NASOPHARYNGEAL ASPIRATION; NEUTROPHIL COUNT; PANDEMIC INFLUENZA; PERICARDIAL EFFUSION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; TREATMENT DURATION; URINE CULTURE; VIRUS CULTURE; VIRUS PNEUMONIA; VIRUS STRAIN;

SUIDAE;

EID: 77954887802     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03212.x     Document Type: Article

References (13)

1. Oseltamivir-resistant 2009 pandemic influenza. A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:969-972.
2. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:893-896.
3. Chen H, Cheung CL, Tai H. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis 2009, 15:1970-1972.
4. Mai LQ, Wertheim HFL, Duong TN. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 2009, 362:86-87.
5. Gaur AH, Bagga B, Barman S. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2009, 362:88-89.
6. Jurawan R, de Almeida M, Smith A, Weilert F. Swine H1N1 influenza in a post liver transplant patient. N Z Med J 2009, 122:107-111.
7. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2009, 38(suppl 4):e52-e57.
8. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009, 339:b5106.
9. Gubareva LV. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 2004, 103:199-203.
10. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 2001, 183:523-531.
11. Ives JA, Carr JA, Mendel DB. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 2002, 55:307-317.
12. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003, 348:867-868.
13. Kharfan-Dabaja MA, Velez A, Richards K, Greene JN, Field T, Sandin R. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol 2010, 91:124-127.